KWR:NYSEQuaker Houghton Analysis
Data as of 2026-06-07 - not real-time
$140.69
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
KWR is trading near its 20‑day moving average, indicating a neutral price stance. The stock sits above its 50‑day SMA but below the 200‑day SMA, suggesting limited upward momentum. Technicals show a bearish MACD histogram and a decreasing volume trend, which dampens short‑term optimism. Support rests around the low‑130 level while resistance hovers near the mid‑150 range, framing a relatively tight trading corridor. The 30‑day volatility is elevated, reflecting price swings that exceed typical market moves. With a beta above one, the equity is more sensitive to broader market fluctuations.
Fundamentally, the company reports modest revenue growth and a solid gross margin for a specialty chemical player. Profitability is thin, with a profit margin barely above zero and a low ROE, underscoring earnings fragility. The trailing PE is astronomically high, while the forward PE contracts to a more reasonable level, highlighting expectations of accelerating earnings. The DCF fair‑value estimate is substantially below the current market price, pointing to a clear overvaluation gap. Dividend yield is modest but the payout ratio is extremely low, making the dividend appear sustainable under current cash flow. Analyst consensus is neutral with no strong recommendation, aligning with the mixed technical and fundamental signals.
Fundamentally, the company reports modest revenue growth and a solid gross margin for a specialty chemical player. Profitability is thin, with a profit margin barely above zero and a low ROE, underscoring earnings fragility. The trailing PE is astronomically high, while the forward PE contracts to a more reasonable level, highlighting expectations of accelerating earnings. The DCF fair‑value estimate is substantially below the current market price, pointing to a clear overvaluation gap. Dividend yield is modest but the payout ratio is extremely low, making the dividend appear sustainable under current cash flow. Analyst consensus is neutral with no strong recommendation, aligning with the mixed technical and fundamental signals.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support level
- bearish MACD histogram
- decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- forward earnings upside
- more reasonable forward PE
- sustainable dividend payout
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- persistent overvaluation relative to DCF
- thin profit margins
- moderate sector cyclicality
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin0.22%
P/E Ratio562.8
ROE0.32%
ROA4.34%
Debt/Equity65.95
P/B Ratio1.8
Op. Cash Flow$143.3M
Free Cash Flow$108.4M
Technical Analysis
TrendNeutral
RSI49.8
Support$130.36
Resistance$150.58
MA 20$141.95
MA 50$136.45
MA 200$140.11
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Fair Value$75.55
Target Price$169.50
Upside/Downside20.48%
GradeOvervalued
TypeBlend
Dividend Yield1.44%
Risk Assessment
Beta1.30
Volatility36.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.